GPBAR1 and metabolic dysfunction-associated steatotic liver disease: To sum up, increased BAs after SG improved metabolism in NAFLD by promoting cAMP expression through the activation of GPBAR1, which provides theoretical reference for NAFLD treatment with BAs after SG surgery.